Intensity-Modulated Radiation Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck Interventions: Drug: Xevinapant; Drug: Placebo; Drug: cetuximab; Radiation: IMRT Sponsor: Groupe Oncologie Radiotherapie Tete et Cou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials
